Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Long-Term Investments (2019 - 2023)

Cresco Labs (CRLBF) has disclosed Long-Term Investments for 5 consecutive years, with $730000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Long-Term Investments fell 40.55% year-over-year to $730000.0, compared with a TTM value of $730000.0 through Dec 2023, down 40.55%, and an annual FY2023 reading of $730000.0, down 40.55% over the prior year.
  • Long-Term Investments was $730000.0 for Q4 2023 at Cresco Labs, down from $1.2 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $5.9 million in Q4 2021 and bottomed at $730000.0 in Q4 2023.
  • Average Long-Term Investments over 5 years is $2.7 million, with a median of $1.3 million recorded in 2019.
  • The sharpest move saw Long-Term Investments surged 241.16% in 2020, then crashed 79.23% in 2022.
  • Year by year, Long-Term Investments stood at $1.3 million in 2019, then soared by 241.16% to $4.4 million in 2020, then surged by 35.6% to $5.9 million in 2021, then crashed by 79.23% to $1.2 million in 2022, then crashed by 40.55% to $730000.0 in 2023.
  • Business Quant data shows Long-Term Investments for CRLBF at $730000.0 in Q4 2023, $1.2 million in Q4 2022, and $5.9 million in Q4 2021.